IO Therapeutics, Inc.

The Woodlands, TX

UEI
TDXKKJF3U5E4
CAGE
6TFK1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1950 Hughes Landing Blvd #812, The Woodlands, TX 77380, USA
Website
io-therapeutics.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of the RXR agonist IRX4204 to treat multiple sclerosis and other immu R43AI112512 National Institutes of Health $225,000
Development of the RXR agonist IRX4204 to treat multiple sclerosis and other immune related diseases R44AI112512 National Institute of Allergy and Infectious Diseases (NIH) $1,854,395

Quick answers

Is IO Therapeutics, Inc. registered in SAM.gov?

Yes. IO Therapeutics, Inc.'s SAM.gov registration is active through July 13, 2027.

What is IO Therapeutics, Inc.'s most recent federal award?

IO Therapeutics, Inc.'s most recent federal grant award is Development of the RXR agonist IRX4204 to treat multiple sclerosis and other immu (R43AI112512), from National Institutes of Health, on June 11, 2014.

On GovTribe

See IO Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login